• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

作者信息

Kraan W, van Keimpema M, Horlings H M, Schilder-Tol E J M, Oud M E C M, Noorduyn L A, Kluin P M, Kersten M J, Spaargaren M, Pals S T

机构信息

Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Pathology Laboratory, Dordrecht, The Netherlands.

出版信息

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20.

DOI:10.1038/leu.2013.348
PMID:24253023
Abstract
摘要

相似文献

1
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.原发性睾丸弥漫性大B细胞淋巴瘤中致癌性MYD88和CD79B突变的高发生率。
Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20.
2
Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.原发性睾丸弥漫性大B细胞淋巴瘤（DLBCL）与胃肠道DLBCL之间，CD79B和MYD88的突变频率差异很大。
Leuk Lymphoma. 2018 May;59(5):1260-1263. doi: 10.1080/10428194.2017.1370546. Epub 2017 Sep 3.
3
MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.CD5阳性弥漫性大B细胞淋巴瘤中的MYD88、CD79B和CARD11基因突变
Cancer. 2017 Apr 1;123(7):1166-1173. doi: 10.1002/cncr.30404. Epub 2016 Dec 4.
4
High prevalence of and mutations in intravascular large B-cell lymphoma.血管内大B细胞淋巴瘤中 和 突变的高发生率。 （你提供的原文中有缺失内容，我按照完整格式翻译了）
Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7.
5
Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.中枢神经系统复发的弥漫性大B细胞淋巴瘤缺乏致癌性MYD88和CD79B突变。
Blood Cancer J. 2014 Dec 12;4(12):e266. doi: 10.1038/bcj.2014.87.
6
Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.原发性中枢神经系统弥漫性大B细胞淋巴瘤中致癌性MYD88和CD79B突变的发生率显著较高。
Leuk Lymphoma. 2015 Jul;56(7):2141-5. doi: 10.3109/10428194.2014.979413. Epub 2015 Jan 14.
7
Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.原发性中枢神经系统弥漫性大B细胞淋巴瘤中MYD88和CD79B突变频率以及MGMT甲基化情况
Neuropathology. 2017 Dec;37(6):509-516. doi: 10.1111/neup.12405. Epub 2017 Aug 30.
8
Morphologic Patterns and the Correlation With MYD88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma.原发肾上腺弥漫性大 B 细胞淋巴瘤的形态学模式及与 MYD88 L265P、CD79B 突变的相关性。
Am J Surg Pathol. 2020 Apr;44(4):444-455. doi: 10.1097/PAS.0000000000001386.
9
MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.MYD88、CARD11和CD79B致癌突变在印度初发性淋巴结弥漫性大B细胞淋巴瘤队列中是罕见事件。
Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):311-318. doi: 10.1097/PAI.0000000000000585.
10
Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.原发性中枢神经系统弥漫性大 B 细胞淋巴瘤的克隆演变。
Appl Immunohistochem Mol Morphol. 2020 Sep;28(8):e68-e71. doi: 10.1097/PAI.0000000000000655.

引用本文的文献

1
Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma.一种新型CD19、CD22双靶点全人源环状双特异性嵌合抗原受体T细胞（bi-CAR-T）治疗复发/难治性B细胞非霍奇金淋巴瘤的疗效和安全性
J Transl Med. 2025 Jun 5;23(1):630. doi: 10.1186/s12967-025-06567-3.
2
A Rare Case of Adrenal Intravascular Large B-Cell Lymphoma Diagnosed via Percutaneous Needle Biopsy.经皮穿刺活检诊断肾上腺血管内大B细胞淋巴瘤1例罕见病例
World J Surg Oncol. 2025 May 23;23(1):200. doi: 10.1186/s12957-025-03855-6.
3
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

本文引用的文献

1
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.在免疫特权部位出现的弥漫性大 B 细胞淋巴瘤中，存在高频率的致癌 MYD88 和 CD79B 突变。
Blood Cancer J. 2013 Sep 6;3(9):e139. doi: 10.1038/bcj.2013.28.
2
The genetic basis of diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的遗传学基础。
Curr Opin Hematol. 2013 Jul;20(4):336-44. doi: 10.1097/MOH.0b013e3283623d7f.
3
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.瓦尔登斯特伦巨球蛋白血症中的 MYD88 L265P 体细胞突变。
结外弥漫性大B细胞淋巴瘤：来自多中心EXPECT研究的临床与分子见解及生存结局
Cancer Commun (Lond). 2025 Aug;45(8):919-935. doi: 10.1002/cac2.70033. Epub 2025 May 8.
4
High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.大剂量甲氨蝶呤、伊布替尼和替莫唑胺治疗新诊断的原发性中枢神经系统淋巴瘤：一项多中心前瞻性II期研究
Blood Cancer Discov. 2025 May 5;6(3):191-202. doi: 10.1158/2643-3230.BCD-24-0156.
5
Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.日本人群甲状腺大B细胞淋巴瘤的临床病理及基因分析
J Clin Exp Hematop. 2024 Dec 25;64(4):286-291. doi: 10.3960/jslrt.24010. Epub 2024 Oct 28.
6
Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.以R-CHOP加用大剂量甲氨蝶呤作为一线治疗方案的睾丸受累大B细胞淋巴瘤患者的生物学发现与临床结局
Eur J Haematol. 2025 Jan;114(1):186-194. doi: 10.1111/ejh.14325. Epub 2024 Oct 12.
7
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.睾丸大B细胞淋巴瘤在基因上与原发性中枢神经系统淋巴瘤相似，且与淋巴结弥漫性大B细胞淋巴瘤不同。
Hemasphere. 2024 Oct 7;8(10):e70024. doi: 10.1002/hem3.70024. eCollection 2024 Oct.
8
Next-generation sequencing of primary testicular lymphoma and relapse in the glans penis after prophylactic radiation therapy: a rare case report.原发睾丸淋巴瘤的下一代测序和预防性放疗后龟头复发：罕见病例报告。
Diagn Pathol. 2024 Jun 3;19(1):72. doi: 10.1186/s13000-024-01498-x.
9
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications.B细胞肿瘤的新分类：世界卫生组织第5版分类与国际共识分类的比较
Int J Hematol. 2025 Mar;121(3):331-341. doi: 10.1007/s12185-024-03781-5. Epub 2024 May 28.
10
Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.原发性睾丸淋巴瘤的基因组图谱和独特分子亚型。
J Transl Med. 2024 May 1;22(1):414. doi: 10.1186/s12967-024-05140-8.
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.
4
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.原发性中枢神经系统淋巴瘤中 MYD88 和 TBL1XR1 的反复突变。
Clin Cancer Res. 2012 Oct 1;18(19):5203-11. doi: 10.1158/1078-0432.CCR-12-0845. Epub 2012 Jul 26.
5
Primary testicular lymphoma.原发性睾丸淋巴瘤。
Clin Oncol (R Coll Radiol). 2012 Jun;24(5):358-65. doi: 10.1016/j.clon.2012.02.005. Epub 2012 Mar 17.
6
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.临床上有效的 BTK 抑制剂 PCI-32765 靶向慢性淋巴细胞白血病中 B 细胞受体和趋化因子控制的黏附和迁移。
Blood. 2012 Mar 15;119(11):2590-4. doi: 10.1182/blood-2011-11-390989. Epub 2012 Jan 25.
7
Pathogenesis of human B cell lymphomas.人类 B 细胞淋巴瘤的发病机制。
Annu Rev Immunol. 2012;30:565-610. doi: 10.1146/annurev-immunol-020711-075027. Epub 2012 Jan 6.
8
Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.MYD88基因的激活型L265P突变在原发性中枢神经系统淋巴瘤中很常见。
Acta Neuropathol. 2011 Dec;122(6):791-2. doi: 10.1007/s00401-011-0891-2. Epub 2011 Oct 22.
9
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.利妥昔单抗-CHOP、中枢神经系统预防和对侧睾丸照射治疗原发性睾丸弥漫性大 B 细胞淋巴瘤的一线治疗：国际 II 期试验的最终结果。
J Clin Oncol. 2011 Jul 10;29(20):2766-72. doi: 10.1200/JCO.2010.31.4187. Epub 2011 Jun 6.
10
Oncogenically active MYD88 mutations in human lymphoma.人类淋巴瘤中致癌性激活的 MYD88 突变。
Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.